chevron_leftBack
As of 24 April 2025, Koa Shoji Holdings Co.,Ltd. has a market cap of $201.0M USD, ranking #17167 globally and #1615 in Japan. It ranks #1706 in the Healthcare sector, and #410 in the Drug Manufacturers - Specialty & Generic industry.
Key Stats
Market Cap
$201.0MUSD
28.64B JPY
Enterprise Value
$131.12MUSD
18.76B JPY
Revenue (TTM)
$161.49MUSD
23.01B JPY
EBITDA (TTM)
$40.3MUSD
5.77B JPY
Net Income (TTM)
$24.09MUSD
3.43B JPY
EBITDA Margin
25%
Profit Margin
15%
PE Ratio
8.1
Company Profile
Country (HQ)
Sector
Healthcare
CEO
Toshiyuki Shuto
open_in_new
Employees
289
Founded
1991
Website
koashoji-hd.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -1.6% | 4.6% | -7.6% | 10% | 13% | -17% |
Upcoming Earnings
Earnings Date
Mon, May 12
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
9273
コーア商事ホールディングス（株） Ordinary Shares
ISIN: JP3283420002
Shares Out.:
Shares Outstanding:
42.119M1
Shares Float:
12.937M2
|
669 JPY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Koa Shoji Holdings Co.,Ltd.
Koa Shoji Holdings Co.,Ltd., through its subsidiaries, imports and sells active pharmaceutical ingredients (APIs) in Japan. The company is involved in the manufacture and marketing of OTC drugs and health foods; primarily various vitamins; and manufacture and sale of generic APIs and drugs, as well as pharmaceuticals comprising injections. It also engages in contract manufacturing of pharmaceuticals; packaging of pharmaceutical products; and purchase and sale of pharmaceuticals. Koa Shoji Holdings Co.,Ltd. was founded in 1991 and is headquartered in Yokohama, Japan.
